Atom Investors LP Equillium, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.03 - $10.5 $63,795 - $133,171	-12,683 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.48 - $6.58 $44,136 - $83,454	12,683 New	12,683 $68,000
Q2 2019 Aug 14, 2019	SELL	$5.28 - $8.2 $63,016 - $97,866	-11,935 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.84 - $12.02 $509,592 - $1.05 Million	-87,259 Reduced 87.97%	11,935 $95,000
Q4 2018 Feb 14, 2019	BUY	$6.32 - $19.44 $626,906 - $1.93 Million	99,194 New	99,194 $809,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.